348 related articles for article (PubMed ID: 7684043)
1. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
Blei F; Wilson EL; Mignatti P; Rifkin DB
J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043
[TBL] [Abstract][Full Text] [Related]
2. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.
Pepper MS; Rosnoblet C; Di Sanza C; Kruithof EK
Thromb Haemost; 2001 Aug; 86(2):702-9. PubMed ID: 11522025
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro.
Montesano R; Kumar S; Orci L; Pepper MS
Lab Invest; 1996 Aug; 75(2):249-62. PubMed ID: 8765325
[TBL] [Abstract][Full Text] [Related]
5. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells.
Pepper MS; Wasi S; Ferrara N; Orci L; Montesano R
Exp Cell Res; 1994 Feb; 210(2):298-305. PubMed ID: 7507853
[TBL] [Abstract][Full Text] [Related]
6. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases.
Kim MH
J Cell Biochem; 2003 Jun; 89(3):529-38. PubMed ID: 12761886
[TBL] [Abstract][Full Text] [Related]
7. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
Fibbi G; D'Alessio S; Pucci M; Cerletti M; Del Rosso M
Biol Chem; 2002 Jan; 383(1):127-36. PubMed ID: 11928807
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity.
Odekon LE; Sato Y; Rifkin DB
J Cell Physiol; 1992 Feb; 150(2):258-63. PubMed ID: 1734031
[TBL] [Abstract][Full Text] [Related]
9. Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity.
Flaumenhaft R; Abe M; Mignatti P; Rifkin DB
J Cell Biol; 1992 Aug; 118(4):901-9. PubMed ID: 1380001
[TBL] [Abstract][Full Text] [Related]
10. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
[TBL] [Abstract][Full Text] [Related]
11. Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells.
Peverali FA; Mandriota SJ; Ciana P; Marelli R; Quax P; Rifkin DB; Della Valle G; Mignatti P
J Cell Physiol; 1994 Oct; 161(1):1-14. PubMed ID: 7523424
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
Korner G; Bjornsson TD; Vlodavsky I
J Cell Physiol; 1993 Mar; 154(3):456-65. PubMed ID: 8436596
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.
Liu JW; Wei DZ; Du CB; Zhong JJ
Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716
[TBL] [Abstract][Full Text] [Related]
14. Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis.
Pepper MS; Vassalli JD; Wilks JW; Schweigerer L; Orci L; Montesano R
J Cell Biochem; 1994 Aug; 55(4):419-34. PubMed ID: 7525617
[TBL] [Abstract][Full Text] [Related]
15. A role of fibrinolytic activity in angiogenesis. Quantitative assay using in vitro method.
Yasunaga C; Nakashima Y; Sueishi K
Lab Invest; 1989 Dec; 61(6):698-704. PubMed ID: 2481153
[TBL] [Abstract][Full Text] [Related]
16. Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis.
Flaumenhaft R; Moscatelli D; Saksela O; Rifkin DB
J Cell Physiol; 1989 Jul; 140(1):75-81. PubMed ID: 2738111
[TBL] [Abstract][Full Text] [Related]
17. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
18. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
[TBL] [Abstract][Full Text] [Related]
19. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.
Takano S; Gately S; Neville ME; Herblin WF; Gross JL; Engelhard H; Perricone M; Eidsvoog K; Brem S
Cancer Res; 1994 May; 54(10):2654-60. PubMed ID: 7513254
[TBL] [Abstract][Full Text] [Related]
20. Regulation of basic fibroblast growth factor (bFGF) gene and protein expression following its release from sublethally injured endothelial cells.
Ku PT; D'Amore PA
J Cell Biochem; 1995 Jul; 58(3):328-43. PubMed ID: 7593255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
